title: Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection.
abstract: Epidemiological studies indicate that the exogenous sex steroid medroxyprogesterone acetate (MPA) can impair cell-mediated immunity, but mechanisms responsible for this observation are not well defined. In this study, MPA administered to mice 1 wk prior to HSV type 1 (HSV-1) infection of their corneal mucosa impaired initial expansion of viral-specific effector and memory precursor T cells and reduced the number of viral-specific memory T cells found in latently infected mice. MPA treatment also dampened expression of the costimulatory molecules CD40, CD70, and CD80 by dendritic cells (DC) in lymph nodes draining acute infection, whereas coculture of such DC with T cells from uninfected mice dramatically impaired ex vivo T cell proliferation compared with the use of DC from mice that did not receive MPA prior to HSV-1 infection. In addition, T cell expansion was comparable to that seen in untreated controls if MPA-treated mice were administered recombinant soluble CD154 (CD40L) concomitant with their mucosal infection. In contrast, the immunomodulatory effects of MPA were infection site dependent, because MPA-treated mice exhibited normal expansion of virus-specific T cells when infection was systemic rather than mucosal. Taken together, our results reveal that the administration of MPA prior to viral infection of mucosal tissue impairs DC activation, virus-specific T cell expansion, and development of virus-specific immunological memory.
authors.affiliation: Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
authors.forename: Rodolfo D
authors.initials: RD
authors.lastname: Vicetti Miguel
authors.forename: Robert L
authors.initials: RL
authors.lastname: Hendricks
authors.forename: Alfredo J
authors.initials: AJ
authors.lastname: Aguirre
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Melan
authors.forename: Stephen A K
authors.initials: SA
authors.lastname: Harvey
authors.forename: Tracy
authors.initials: T
authors.lastname: Terry-Allison
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: St Leger
authors.forename: Angus W
authors.initials: AW
authors.lastname: Thomson
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Cherpes
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology*; D002478:Cells, Cultured; D018920:Coculture Techniques; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology* / Q000821:virology*; D005260:Female; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000276:immunology*; D007111:Immunity, Cellular / Q000187:drug effects; D007156:Immunologic Memory / Q000187:drug effects; D016849:Keratitis, Herpetic / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009092:Mucous Membrane / Q000187:drug effects / Q000276:immunology / Q000473:pathology
chemical_list: D017258:Medroxyprogesterone Acetate